相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-hyperglycemic and anti-hyperlipidemic effects of a special fraction of Luohanguo extract on obese T2DM rats
Yulong Zhang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2020)
Evaluation of Mogroside V as a Promising Carrier in Drug Delivery: Improving the Bioavailability and Liver Distribution of Silybin
Yuqin Luo et al.
AAPS PHARMSCITECH (2020)
Mogroside derivatives exert hypoglycemics effects by decreasing blood glucose level in HepG2 cells and alleviates insulin resistance in T2DM rats
Xuan Liu et al.
JOURNAL OF FUNCTIONAL FOODS (2019)
The metabolism of a natural product mogroside V, in healthy and type 2 diabetic rats
Guisheng Zhou et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2018)
Mechanism of antidiabetic and synergistic effects of ginseng polysaccharide and ginsenoside Rb1 on diabetic rat model
Jing Li et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2018)
Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?
Antonio Sircana et al.
CURRENT DIABETES REPORTS (2018)
Review of Pharmacokinetic Data of Different Drug Classes in Goto-Kakizaki Rats, a Non-obese Model for Type 2 Diabetes Mellitus: Case Studies and Perspectives
Harilal Patel et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2017)
Biotransformation of Total Saponins in Siraitia Fructus by Human Intestinal Microbiota of Normal and Type 2 Diabetic Patients: Comprehensive Metabolite Identification and Metabolic Profile Elucidation Using LC-Q-TOF/MS
Guisheng Zhou et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2017)
Mogroside IIIE, a Novel Anti-Fibrotic Compound, Reduces Pulmonary Fibrosis through Toll-Like Receptor 4 Pathways
Lijun Tao et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Metabolites of Siamenoside I and Their Distributions in Rats
Xue-Rong Yang et al.
MOLECULES (2016)
The complex task of measuring intestinal permeability in basic and clinical science
H. J. Galipeau et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2016)
In vitro AMPK activating effect and in vivo pharmacokinetics of mogroside V, a cucurbitane-type triterpenoid from Siraitia grosvenorii fruits
Zuliang Luo et al.
RSC ADVANCES (2016)
Exploring in vitro, in vivo metabolism of mogroside V and distribution of its metabolites in rats by HPLC-ESI-IT-TOF-MSn
Feng Xu et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2015)
Sweeteners from plants-with emphasis on Stevia rebaudiana (Bertoni) and Siraitia grosvenorii (Swingle)
Rahul S. Pawar et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2013)
Effect of Diabetes Mellitus on Pharmacokinetic and Pharmacodynamic Properties of Drugs
Miroslav Dostalek et al.
CLINICAL PHARMACOKINETICS (2012)
Position of the Academy of Nutrition and Dietetics: Use of Nutritive and Nonnutritive Sweeteners
Cindy Fitch et al.
JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS (2012)
Digestion and Absorption of Siraitia grosvenori Triterpenoids in the Rat
Yuji Murata et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2010)
Cucurbitane glycosides from unripe fruits of Siraitia grosvenori
Dianpeng Li et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2007)
Antidiabetic effect of long-term supplementation with Siraitia grosvenori on the spontaneously diabetic Goto-Kakizaki rat
Yasushi A. Suzuki et al.
BRITISH JOURNAL OF NUTRITION (2007)
Effect of a Siraitia grosvenori extract contalning mogrosides on the cellular immune system of type 1 diabetes mellitus mice
Qi Xiangyang et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2006)
Changes in intestinal morphology and permeability in the BioBreeding rat before the onset of type 1 diabetes
J Neu et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2005)
分享论文
